The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Benign Breast Disorders
Abstract
About 50 percent of women have histologic evidence of some degree of fibrocystic changes in the breast. This review article describes the spectrum of benign breast disorders, including those that increase the risk of malignant disease. The authors explain the evaluation and management of breast pain, breast discharge, and focal lesions, as well as the options that can prevent progression to breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Overview of the main outcomes in breast-cancer prevention trials
Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 965
Benign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044383 · Cited by 938
Mammographic densities and breast cancer risk.
Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D., & Yaffe, M. J. (1998) · PubMed · Cited by 810
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women
Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., & Speizer, F. E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1292 · Cited by 687
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
Heritability of Mammographic Density, a Risk Factor for Breast Cancer
Boyd, N. F., Dite, G. S., Stone, J., Gunasekara, A., English, D. R., McCredie, M. R. E., Giles, G. G., Tritchler, D., Chiarelli, A., Yaffe, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013390 · Cited by 611
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
Roger, P., Sahla, M. E., Mäkelä, S., Gustafsson, J. A., Baldet, P., & Rochefort, H. (2001) · PubMed · Cited by 551
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia
Dupont, W. D., Parl, F. F., Hartmann, W. H., Brinton, L. A., Winfield, A. C., Worrell, J. A., Schuyler, P. A., & Plummer, W. D. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i · Cited by 528
Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers
Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S., Willson, J. K. V., Parmigiani, G., Kinzler, K. W., et al. (2003) · Science · doi:10.1126/science.1082596 · Cited by 484
Histological and biological evolution of human premalignant breast disease.
Allred, D. C., Mohsin, S. K., & Fuqua, S. A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080047 · Cited by 416
Barton, M. B., Harris, R., & Fletcher, S. W. (1999) · JAMA · doi:10.1001/jama.282.13.1270 · Cited by 375
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340
Breast cancer: hormones and other risk factors
Hulka, B. S., & Moorman, P. G. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00196-1 · Cited by 314
The effect of age and menstrual cycle upon proliferative activity of the normal human breast
Potten, C., Watson, R., Williams, G., Tickle, S., Roberts, S., Harris, M., & Howell, A. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.185 · Cited by 311
Wolfe, J., Saftlas, A., & Salane, M. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.148.6.1087 · Cited by 277
Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer
Dooley, W. C., Ljung, B.-M., Veronesi, U., Cazzaniga, M., Elledge, R. M., O'Shaughnessy, J. A., Kuerer, H. M., Hung, D. T., Khan, S. A., Phillips, R. F., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1624 · Cited by 273
Chlebowski, R. T., Col, N., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G., Burstein, H. J., Eisen, A., Lipkus, I., & Pfister, D. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.029 · Cited by 197
A prospective study of benign breast disease and the risk of breast cancer
London, S. J. (1992) · JAMA · doi:10.1001/jama.267.7.941 · Cited by 178
Chlebowski, R. T., Collyar, D. E., Somerfield, M. R., & Pfister, D. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1939 · Cited by 164
Hoogerbrugge, N., Bult, P., de Widt-Levert, L. M., Beex, L. V. A. M., Kiemeney, L. A. L. M., Ligtenberg, M. J. L., Massuger, L., Boetes, C., Manders, P., & Brunner, H. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.137 · Cited by 149
Hyperprolactinemia: Etiology, Diagnosis, and Management
Mah, P. M., & Webster, J. (2002) · Seminars in Reproductive Medicine · doi:10.1055/s-2002-36709 · Cited by 148
Cyclical mastalgia: prevalence and associated health and behavioral factors
Ader, D. N., South-Paul, J. E., Adera, T., & Deuster, P. A. (2001) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674820109049956 · Cited by 146
Epidemiology of Benign Breast Disease, with Special Attention to Histologic Types
Goehring, C., & Morabia, A. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017960 · Cited by 141
O’Brien, P. M. S., & Abukhalil, I. E. H. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70142-0 · Cited by 127
Lower-Category Benign Breast Disease and the Risk of Invasive Breast Cancer
Wang, J., Costantino, J. P., Tan-Chiu, E., Wickerham, D. L., Paik, S., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djhs105 · Cited by 119
Persistent Changes in Gene Expression Induced by Estrogen and Progesterone in the Rat Mammary Gland
Ginger, M. R., Gonzalez-Rimbau, M. F., Gay, J. P., & Rosen, J. M. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0724 · Cited by 118
Kessel, B. (2000) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70160-1 · Cited by 109
Effects of mammographic density and benign breast disease on breast cancer risk (United States)
Byrne, C., Schairer, C., Brinton, L. A., Wolfe, J. N., Parekh, N. J., Salane, M., Carter, C., & Hoover, R. N. (2001) · Cancer Causes & Control · doi:10.1023/a:1008935821885 · Cited by 107
Drug Treatments for Mastalgia: 17 Years Experience in the Cardiff Mastalgia Clinic
Gateley, C., Miers, M. E., Mansel, R. E., & Hughes, L. E. (1992) · Journal of the Royal Society of Medicine · doi:10.1177/014107689208500105 · Cited by 104
Self-citationBoyd, N. F., Jensen, H. M., Cooke, G., Han, H.-J., Lockwood, G. A., & Miller, A. B. (2000) · European Journal of Cancer Prevention · doi:10.1097/00008469-200002000-00003 · Cited by 91
Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.
McTiernan, A., Kuniyuki, A. A., Yasui, Y., Bowen, D. J., Burke, W., Culver, J. B., Anderson, R. H., & Durfy, S. J. (2001) · PubMed · Cited by 82
Levine, M., Moutquin, J., Walton, R., & Feightner, J. (2001) · Europe PMC (PubMed Central) · Cited by 79
Blommers, J., de Klerk, E. S. M. D. L., Kuik, D. J., Bezemer, P. D., & Meijer, S. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.127377a · Cited by 77
Clinical Management of Breast Pain: A Review
Millet, A. V., & Dirbas, F. M. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200207000-00022 · Cited by 74
Shetty, M. K., Shah, Y. P., & Sharman, R. S. (2003) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2003.22.3.263 · Cited by 66
Khan, S. A., & Apkarian, A. V. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1019685829799 · Cited by 60
Treatment of Premenstrual Mastalgia with Tamoxifen
Messinis, I. E., Lolis, D. E., & Messinis, I. E. (1988) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.1988.tb07804.x · Cited by 58
European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia
Mansel, R. E., Goyal, A., PREECE, P. E., Leinster, S., Maddox, P. R., Gateley, C., Kubista, E., & von Fournier, D. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.100 · Cited by 54
Self-citationSex steroid hormones, bone mineral density, and risk of breast cancer.
Kuller, L. H., Cauley, J. A., Lucas, L., et al. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s3593 · Cited by 43
Charreau, I., Plu‐Bureau, G., Bachelot, A., et al. (1993) · European Journal of Cancer Prevention · doi:10.1097/00008469-199303000-00007 · Cited by 32
Boone, C. W., Kelloff, G. J., & Freedman, L. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531104 · Cited by 30
Chemoprevention of Breast Cancer: Current and Future Prospects
Pappas, S. G., & Jordan, V. C. (2002) · Cancer and Metastasis Reviews · doi:10.1023/a:1021219212638 · Cited by 24
Cited by
Benign Breast Diseases: Classification, Diagnosis, and Management
Guray, M., & Sahin, A. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-435 · Cited by 392
Atypical Hyperplasia of the Breast — Risk Assessment and Management Options
Hartmann, L. C., Degnim, A. C., Santen, R. J., Dupont, W. D., & Ghosh, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1407164 · Cited by 366
Self-citationCowden Syndrome: A Critical Review of the Clinical Literature
Pilarski, R. (2009) · Journal of Genetic Counseling · doi:10.1007/s10897-008-9187-7 · Cited by 311
Zinc in Specialized Secretory Tissues: Roles in the Pancreas, Prostate, and Mammary Gland
Kelleher, S. L., McCormick, N. H., Velasquez, V., & Lopez, V. (2011) · Advances in Nutrition · doi:10.3945/an.110.000232 · Cited by 263
Metadata
- Authors
- Santen, R. J., & Mansel, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-07-21
- Volume
- 353
- Issue
- 3
- Pages
- 275-285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2054610155
- Cited by
- 358
- References
- 46
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.